Suppr超能文献

利用新型来自倭黑猩猩的猴腺病毒载体 PanAd3 对保守流感抗原进行疫苗接种实验,该载体来源于倭黑猩猩 Pan paniscus。

Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.

机构信息

Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration,Bethesda, Maryland, United States of America.

出版信息

PLoS One. 2013;8(3):e55435. doi: 10.1371/journal.pone.0055435. Epub 2013 Mar 11.

Abstract

Among approximately 1000 adenoviruses from chimpanzees and bonobos studied recently, the Pan Adenovirus type 3 (PanAd3, isolated from a bonobo, Pan paniscus) has one of the best profiles for a vaccine vector, combining potent transgene immunogenicity with minimal pre-existing immunity in the human population. In this study, we inserted into a replication defective PanAd3 a transgene expressing a fusion protein of conserved influenza antigens nucleoprotein (NP) and matrix 1 (M1). We then studied antibody and T cell responses as well as protection from challenge infection in a mouse model. A single intranasal administration of PanAd3-NPM1 vaccine induced strong antibody and T cell responses, and protected against high dose lethal influenza virus challenge. Thus PanAd3 is a promising candidate vector for vaccines, including universal influenza vaccines.

摘要

在最近研究的大约 1000 种来自黑猩猩和倭黑猩猩的腺病毒中,Pan 腺病毒 3 型(PanAd3,从倭黑猩猩 Pan paniscus 中分离出来)是一种疫苗载体,具有最佳特性之一,它具有强大的转基因免疫原性,同时在人群中具有最小的预先存在的免疫性。在这项研究中,我们将一个表达保守流感抗原核蛋白(NP)和基质 1(M1)融合蛋白的转基因插入到复制缺陷的 PanAd3 中。然后,我们在小鼠模型中研究了抗体和 T 细胞反应以及对挑战感染的保护作用。单次鼻腔内给予 PanAd3-NPM1 疫苗可诱导强烈的抗体和 T 细胞反应,并可预防高剂量致死性流感病毒的挑战。因此,PanAd3 是疫苗的一种有前途的候选载体,包括通用流感疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18d3/3594242/a04d40b20e0c/pone.0055435.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验